Enza
Enza Ceccobelli, Rome IT
Patent application number | Description | Published |
---|---|---|
20130305461 | FABRIC CLEANING COMPOSITION COMPRISING HUEING AGENT - A fabric cleaning composition comprising from 1% to 20% by weight of the fabric cleaning composition of an oxygen-based bleaching source and a hueing agent, and wherein the neat composition has a pH between 2.5 and 5.5, and a method of using said fabric cleaning composition. | 11-21-2013 |
Enza Dinoia, Sant' Arcangelo IT
Patent application number | Description | Published |
---|---|---|
20150111029 | CONSTRUCTION ELEMENT FOR WALLS AND WALL LINING AND PRODUCTION METHOD OF THE ELEMENT - Construction element for walls and wall lining comprising at least one layer of lining material ( | 04-23-2015 |
Enza Di Noia, Sant' Arcangelo IT
Patent application number | Description | Published |
---|---|---|
20150111029 | CONSTRUCTION ELEMENT FOR WALLS AND WALL LINING AND PRODUCTION METHOD OF THE ELEMENT - Construction element for walls and wall lining comprising at least one layer of lining material ( | 04-23-2015 |
Enza Lacivita, Bari IT
Patent application number | Description | Published |
---|---|---|
20140086834 | NEW I-ARYLPIPERAZINIC LIGANDS OF 5-HT7 RECEPTOR AND USE THEREOF - The invention relates to a new class of compounds able to inhibit with high affinity and selectivity the 5-HT7 receptor. The invention also relates to the utilization of such compounds as medicaments useful in the treatment and prevention of 5-HT7 receptor relating disorders of the central nervous system. The invention also relates to the isotopically labeled compounds for use in vivo diagnosis or imaging of a 5-HT7 condition. | 03-27-2014 |
Enza Lonardo, Roma IT
Patent application number | Description | Published |
---|---|---|
20110028401 | CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF - The present invention concerns a monomeric or multimeric tripeptide molecule able of inhibiting Cripto signalling in embryonic stem cells, thereby enhancing dopamine specification and differentiation, after transplantation in animal models of Parkinson's disease, as well as reducing tumor formation, and uses thereof. | 02-03-2011 |